Close Menu

Tecan

Luminex said that it expects to launch the platform, to be called NeoPlex4, in 2011 and "once it receives regulatory clearance, [it] will be a fully automated, walk-away testing platform for multiplexed newborn screening."

NuGen's products will be used for an initiative that the Framingham Heart Study launched last year called the Systems Approach to Biomarker Research in Cardiovascular Disease, or SABRe CVD.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Princeton University, Point-2-Point Genomics, PHRI at UMDNJ/NJMS, and NuGen Technologies awarded US patents.

The method the two companies developed integrates PhyNexus' PhyTip columns with Tecan's Freedom Evo liquid handling platform.

The certification will make it easier for customers to develop diagnostic tests incorporating NuGen's sample prep products. Meantime, Takara will distribute NuGen's next-gen sequencing, microarray, qPCR, and sample prep products in Japan, South Korea, and China.

New Products: Jun 15, 2010

Premium

NuGen's Encore NGS Library/Multiplex Systems and Ovation 3'-DGE System, OpGen's Argus Optical Mapping System

As part of the deal, Takara has rights to offer services using NuGen products in Japan, South Korea, and China.

When most people think of the array market, they might think of the whole-genome genotyping chips sold by firms like Affymetrix and Illumina. But for providers of array slides, printers, and scanners, the market increasingly is in protein chips, and business is good.

The companies have integrated the Freedom EVO and Octet instruments.

Pages

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.